{
  "image_filename": "table_p5_det_4_005.png",
  "image_path": "Zimmerman_et_al.__2023_/extracted/figures/table_p5_det_4_005.png",
  "image_type": "Table",
  "page_number": 5,
  "block_id": "det_4_005",
  "claim_id": "claim_005",
  "claim": "Flublok (quadrivalent) was evaluated in the pivotal trial against Fluarix (quadrivalent standard-dose vaccine).",
  "supports_claim": false,
  "explanation": "Excerpt of text from a clinical document page, reporting efficacy percentages for TVL (an influenza vaccine) in 50\u201364 year olds against RT-PCR confirmed and culture-positive ILI, followed by mention of a retrospective cohort study in Medicare beneficiaries. The provided image does not mention Flublok (quadrivalent) or Fluarix (quadrivalent standard-dose vaccine) nor describe a pivotal trial comparing the two, and therefore does not support the claim. Note: The image is a partial text excerpt unrelated to the claim and contains no table data on Flublok or Fluarix.",
  "model_used": "o4-mini",
  "detailed_analysis": {
    "supports_claim": false,
    "image_description": "Excerpt of text from a clinical document page, reporting efficacy percentages for TVL (an influenza vaccine) in 50\u201364 year olds against RT-PCR confirmed and culture-positive ILI, followed by mention of a retrospective cohort study in Medicare beneficiaries.",
    "evidence_found": null,
    "reasoning": "The provided image does not mention Flublok (quadrivalent) or Fluarix (quadrivalent standard-dose vaccine) nor describe a pivotal trial comparing the two, and therefore does not support the claim.",
    "confidence_notes": "The image is a partial text excerpt unrelated to the claim and contains no table data on Flublok or Fluarix."
  }
}